Modine Company shows AI data center cooling exposure, reaffirmed 2027 guidance, and improving business mix. Learn why MOD ...
Meta (META) stays a Strong Buy as AI boosts ads and engagement. Valuation is compelling at TTM P/OCF of 10. Read here for a ...
ING Groep's Q2 2026 results: revenues +10% YoY, raised 2026/27 outlook, strong NII/fees and RoTE 17%. Read here for more on ...
Palantir is a Strong Buy ahead of Q2 earnings as revenue and profits surge, commercial growth accelerates, and valuation ...
Credo Technology Group Holding Ltd shares have been dropping, down 30%+ from recent highs. Learn more about CRDO stock here.
(DuPont spinoff) beat Q1, raised guidance, and rides AI/data center demand with recurring semiconductor consumables revenue.
Key 2026 catalysts include the trastuzumab pamirtecan BLA filing, pivotal Phase 3 oncology readouts, and a binary EPO patent ...
Q2 recap: new long-term capital strategy for STRC, Bitcoin sales/buybacks, dividend tweaks, and issuance plans amid ...
Edison falls after CEO Pedro Pizarro warned about the possibility that California lawmakers will not pass wildfire liability ...
Qure N.V. downgraded to Hold as AMT-130 faces FDA uncertainty; BLA targeted Q3 2026 with key data due Sept 2026. Click for ...
Enbridge said it is postponing the 250K bbl/day second phase of its Mainline pipeline network, partly due to Canadian oil ...
Adaptive Biotechnologies (ADPT) pivots to pure-play MRD diagnostics as clonoSEQ adoption, margins & backlog surge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results